The "09 Top ten Liver Health news events" was shortlisted for the gem

Every year March 18 is the Chinese love Liver Day, the day of Chinese love Liver network, China Public Relations Network, WO Media Network three major industry portals jointly launched the "China 2009 Top Ten Liver Health news events", from the Liver Health professional field, public relations and social impact, media attention and public opinion guide three angles, The 10 major liver health news events affecting Chinese society in the 2009 were reviewed.　　In 2009, due to the landing of the gem was widely concerned about the shares of the company by virtue of liver fibrosis in the field of science and technology and industry leading role in the list. Hepatic fibrosis is one of the most cutting-edge research directions in the field of liver disease, which is a process of transition from viral hepatitis to cirrhosis. All kinds of chronic liver diseases inevitably lead to a certain degree of liver fibrosis, even after the cause of elimination still independent progress. Liver fibrosis if not timely treatment, further development, will lead to cirrhosis and even life-threatening.　　From the medical professional point of view, liver fibrosis refers to the liver fibrous connective tissue hyperplasia, accompanied by the whole process of chronic hepatitis, so as long as there is inflammation in general, there will be liver fibrosis, inflammation caused by the continuous deposition of connective tissue, to a certain extent, will cause cirrhosis. After several decades of domestic liver disease experts continuous efforts, has been proved to the early diagnosis and treatment of liver fibrosis, can effectively reduce chronic liver disease such as hepatitis B, hepatitis A, alcoholic liver, fatty liver and other harm to the human body.　　At present, the effect of traditional Chinese medicine in the field of liver fibrosis treatment has been widely recognized by the global pharmaceutical industry, and the solution provider of liver fibrosis, represented by the shares of the company, has the highest professional level in the international field. The shares of the company have successfully listed in the Gem and become the first listed companies in China and even globally to take the liver fibrosis solution as its main business. This time, mainly due to the listing of the public and the whole society on the liver fibrosis of the recognition and attention, the health concept of the listing of shares is far greater than its commercial significance.　　And after successful financing, the strength of the industry scale, market share, scientific and technological innovation, financial security and other aspects of the upgrade, will trigger a Chinese liver fibrosis and even liver health industry pattern of reintegration. It is reported that the "2009 Top ten Liver Health news events" is also: the Ministry of Health to establish the abolition of enrolment in the medical examination of hepatitis B policy; hepatitis B virus carriers will receive health certificate; "Love Liver Life" public relief action; "Love Liver Star" series selection activities Rei won the 2009CCTV China Economic figures nomination award; the mother "walks 10 kilometers a day only to cut the liver to save the son; Anhui Huoshan County Hospital hemodialysis caused more than 30 people suffering from hepatitis C;" Dwelling "Hepatitis B discrimination disease not terrible prejudice can be fatal; China's chronic hepatitis B quality of life index released.